Tag: Victor Sandor

Array BioPharma Braftovi triple combo for metastatic colorectal cancer secures FDA breakthrough therapy designation

Array BioPharma secured breakthrough therapy designation from the U.S. Food and Drug Administration (FDA) for encorafenib (BRAFTOVI), in combination with binimetinib (MEKTOVI) and cetuximab for ... Read More